Thermo Scientific TSQ Fortis Plus Essential Plan
Contract Opportunity Analysis
The Drug Enforcement Administration’s Office of Acquisition Management is planning a sole-source firm-fixed-price purchase order for a Thermo Scientific TSQ Fortis Plus Essential Plan. The requirement is for support tied to the specialized instrument and its parts, with Thermo Electron North America LLC identified as the intended source. The acquisition is justified under FAR 13.106-1(b)(1)(i) because Thermo Fisher Scientific is the OEM and alternate providers would invalidate the warranty; it is not a small business set-aside, the NAICS code is 811210, and performance is expected in Sterling, Virginia. Vendors that believe they can meet the requirement may submit a capability statement by April 8, 2026 at 10:00 AM EST to Jose Marin at jose.l.marin@dea.gov, and late submissions will not be accepted.